D'ETTORRE, Gabriella
 Distribuzione geografica
Continente #
NA - Nord America 11.436
EU - Europa 5.015
AS - Asia 1.552
AF - Africa 128
SA - Sud America 80
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.222
Nazione #
US - Stati Uniti d'America 11.271
IT - Italia 2.443
IE - Irlanda 619
IN - India 600
SE - Svezia 554
CN - Cina 412
MY - Malesia 309
FI - Finlandia 291
UA - Ucraina 240
DE - Germania 231
RO - Romania 179
SG - Singapore 166
CA - Canada 153
BG - Bulgaria 110
GB - Regno Unito 94
TG - Togo 91
AR - Argentina 67
FR - Francia 53
AT - Austria 38
BE - Belgio 31
NL - Olanda 31
RU - Federazione Russa 26
HK - Hong Kong 19
TR - Turchia 18
CH - Svizzera 17
PL - Polonia 12
ZA - Sudafrica 10
AU - Australia 9
PH - Filippine 9
ES - Italia 8
GR - Grecia 7
SC - Seychelles 7
BZ - Belize 6
MX - Messico 6
BR - Brasile 5
CL - Cile 5
EG - Egitto 5
ET - Etiopia 5
MK - Macedonia 5
RS - Serbia 4
BJ - Benin 3
HU - Ungheria 3
NO - Norvegia 3
PE - Perù 3
UG - Uganda 3
AD - Andorra 2
AL - Albania 2
DK - Danimarca 2
EU - Europa 2
HR - Croazia 2
IQ - Iraq 2
IR - Iran 2
JP - Giappone 2
LV - Lettonia 2
NG - Nigeria 2
PT - Portogallo 2
TW - Taiwan 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
CI - Costa d'Avorio 1
CY - Cipro 1
ID - Indonesia 1
IS - Islanda 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
PK - Pakistan 1
SA - Arabia Saudita 1
SI - Slovenia 1
TZ - Tanzania 1
YE - Yemen 1
Totale 18.222
Città #
Fairfield 1.765
Chandler 922
Rome 868
Woodbridge 838
Ashburn 811
Houston 658
Seattle 628
Dublin 605
Wilmington 561
Cambridge 535
Dearborn 469
Ann Arbor 388
Princeton 354
San Paolo di Civitate 309
Lawrence 235
Plano 198
Fremont 166
Millbury 165
San Diego 151
Boston 150
Beijing 149
Helsinki 133
Sofia 110
Ottawa 104
Milan 97
Horia 93
Lomé 91
New York 91
Jacksonville 89
Andover 80
Bremen 73
San Mateo 68
Federal 67
Boardman 57
Norwalk 57
Toronto 42
Singapore 40
Des Moines 39
Vienna 30
Phoenix 28
Brussels 26
Hefei 26
Nanjing 26
Falls Church 25
Hebei 22
Kunming 20
Redwood City 20
Bühl 18
Jinan 18
Guangzhou 17
Hong Kong 16
Amsterdam 15
Florence 15
London 15
Los Angeles 15
Nanchang 15
San Jose 15
Buffalo 13
Genoa 13
Paris 13
Perugia 13
Bern 12
Istanbul 11
Hyderabad 10
Ciampino 9
Latina 9
Padova 9
Shanghai 9
Tappahannock 9
Washington 9
Melbourne 8
Napoli 8
Pune 8
Taurisano 8
Torino 8
Bologna 7
Chengdu 7
Dallas 7
Frankfurt am Main 7
Messina 7
Muizenberg 7
Naples 7
Redmond 7
Southend 7
Vejano 7
Belize City 6
Catania 6
Centro 6
Como 6
Kilburn 6
Leawood 6
Leominster 6
Menlo Park 6
Mexico City 6
Pomezia 6
Shenyang 6
Trumbull 6
Turin 6
Warsaw 6
Biancavilla 5
Totale 12.976
Nome #
Linee guida per la diagnosi e terapia dell'Immunodeficienza Comune Variabile (ICV) 321
Fecal microbial transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent clostridium difficile infection patients 147
IFN-α promotes rapid human Treg contraction and late Th1-like Treg decrease 146
Apoptotic epitope-specific CD8+ T cells and interferon signaling intersect in chronic hepatitis C virus infection 142
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 136
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 131
Parietal intrahemispheric source connectivity of resting-state electroencephalographic alpha rhythms is abnormal in Naïve HIV patients 130
Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents 128
HPV vaccination after primary treatment of HPV-related disease across different organ sites: a multidisciplinary comprehensive review and meta-analysis 118
Apoptotic cell signaling in lymphocytes from HIV+ patients during successful therapy 117
Impact of new DAA therapy on real clinical practice: a multicenter region-wide cohort study 114
Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs) 114
Analysis of Th17 and Tc17 frequencies and antiviral defenses in gut-associated lymphoid tissue of chronic HIV-1 positive patients 113
Mobile phone microbial contamination among neonatal unit healthcare workers 105
TRANSMITTED DRUG RESISTANCE MUTATIONS AND TRENDS OF HIV-1 SUBTYPES IN TREATMENT-NAÏVE PATIENTS: A SINGLE CENTER EXPERIENCE 104
null 102
Probiotics differently affect gut-associated lymphoid tissue indolamine-2, 3-dioxygenase mRNA and cerebrospinal fluid neopterin levels in antiretroviral-treated HIV-1 infected patients: A pilot study 100
Retinal involvement and ocular findings in COVID-19 pneumonia patients 100
Probiotic supplementation promotes a reduction in T-cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART-treated HIV-1-positive patients 99
Modulation of tryptophan/serotonin pathway by probiotic supplementation in human immunodeficiency virus-positive patients: preliminary results of a new study approach 98
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 98
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 97
SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients 95
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease 95
Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis 94
Probiotics Reduce Inflammation in Antiretroviral Treated, HIV-Infected Individuals: Results of the "Probio-HIV" Clinical Trial 93
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns 93
Challenges in the management of HIV infection. Update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS 92
Oral bacteriotherapy in patients with COVID-19: a retrospective cohort study 92
A Seven-Year Prospective Study on Spondylodiscitis: Epidemiological and Microbiological Features 90
Diagnostic issues of asymptomatic neurosyphilis in HIV-positive patients. A retrospective study 90
A pilot study on the effects of probiotic supplementation on neuropsychological performance and microRNA-29a-c levels in antiretroviral-treated HIV-1-infected patients 89
Differential induction of type I and III interferon genes in the upper respiratory tract of patients with coronavirus disease 2019 (COVID-19) 89
null 89
Assessment of biventricular function by three-dimensional speckle tracking echocardiography in adolescents and young adults with human immunodeficiency virus infection. a pilot study. 88
Infected chronic ischemic wound topically treated with a multi-strain probiotic formulation: a novel tailored treatment strategy 88
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 88
Challenges in the management of SARS-CoV2 infection. The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19 87
Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients 85
Myeloid and lymphoid activation markers in AIDS and non-AIDS presenters 85
Mutational resistance pattern of HIV type 1 in CD14+ monocytes, CD4+ T cells, and plasma from treated patients 85
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit 84
Ultrasensitive Assessment of Residual HIV Viraemia in HAART-Treated Patients With Persistently Undetectable Plasma HIV-RNA: A Cross-Sectional Evaluation 83
Protein induced by vitamin K absence or antagonist-II (PIVKA-II) specifically increased in Italian hepatocellular carcinoma patients 83
Superinfections in patients treated with teicoplanin as anti SARSCoV2 AGENT 83
Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients 82
Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care teaching hospital in Italy: A retrospective analysis 82
Circulating levels of interleukin-7 in antiretroviral-naïve and highly active antiretroviral therapy-treated HIV-infected patients 82
Expression of the mRNA Levels for MDR1, MRP1, MRP4, and MRP5 IN HIV Antiretroviral Naive Patients: Follow-up at 48 Weeks After the Beginning of Therapy 82
Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients 81
Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients 81
Prevalence of single and multiple natural NS3, NS5A and NS5B resistance-associated substitutions in hepatitis C Virus Genotypes 1-4 in Italy 80
Discordance between genotypic and phenotypic drug resistance profiles in human immunodeficiency virus type 1 strains isolated from peripheral blood mononuclear cells 79
Nox2 activation in covid-19 79
Changes in circulating levels of soluble cell adhesion molecules following highly active antiretroviral treatment of HIV-1-infected patients 78
Abdominal aortic mycotic aneurysm, psoas abscess, and aorto-bisiliac graft infection due to Salmonella typhimurium. 78
Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients 78
Recovery of interleukin-17 production from interleukin-15-stimulated CD4+ mononuclear cells in HIV-1-infected patients with sustained viral suppression 77
Central role of interleukin-15 in human immunodeficiency virus (HIV)-infected patients with visceral leishmaniasis. 76
Accelerated coronary atherosclerosis after execution of percutaneous coronary intervention in patient with HIV/HCV coinfection: case report and review of the literature 76
HIV-2 infection in a migrant from Gambia: the history of the disease combined with phylogenetic analysis revealed the real source of infection 76
Higher levels of osteoprotegerin and immune activation/immunosenescence markers are correlated with concomitant bone and endovascular damage in HIV-suppressed patients 76
Type I/II interferon in HIV-1-infected patients: expression in gut mucosa and in peripheral blood mononuclear cells and its modification upon probiotic supplementation 76
Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection. A scoping review 76
Possible determinants of VSL#3 probiotic failure in preventing gastrointestinal adverse events associated with dacomitinib in patients with advanced non-small-cell lung cancer enrolled in ARCHER-1042 trial 75
Early Atherosclerosis in HIV Infected Subjects on Suppressive Antiretroviral Treatment: Role of Osteoprotegerin. 75
Antiviral activity of fecal water samples from HIV-1 infected subjects treated with a specific probiotic formulation 75
Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities. Is it time to assess the definitions? 74
Carotid artery aneurysm in HIV. A review of case reports in literature 74
null 73
Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects 73
Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases. 73
HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity 73
HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS 72
Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients 72
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 72
Hypoalbuminemia, coagulopathy and vascular disease in covid-19 72
Hospital-acquired infection surveillance in a neonatal intensive care unit 72
Diagnosis of anal human papillomavirus infection: polymerase chain reaction or cytology? 71
IFN-stimulated gene expression is independent of the IFNL4 genotype in chronic HIV-1 infection 71
Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women 71
Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy 70
PRESEPSIN AS A POTENTIAL MARKER FOR BACTERIAL INFECTION RELAPSE IN CRITICAL CARE PATIENTS. A PRELIMINARY STUDY 70
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. 70
Normocaloric low cholesterol diet modulates th17/treg balance in patients with chronic hepatitis C virus infection. 70
Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection 70
Copy-years viremia and risk of virological failure in long-term-treated HIV patients 70
Malaria in an asylum seeker paediatric liver transplant recipient: diagnostic challenges for migrant population 70
CASCADE EFFECT OF IL-15, IL-17 AND IL-22 IN HIV INFECTION 69
Switching from protease inhibitors to a single-class regimen of abacavir/lamivudine/zidovudine plus tenofovir in patients with HIV load suppression. 69
PS3-47 IL15 triggers the in vitro production of IL17 from CD4+ T cells of HIV-1 infected patients 69
null 69
null 69
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 69
High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients 69
Prevalence and predictors of long corrected QT interval in HIV-positive patients. a multicenter study 69
Cross-presentation of caspase-cleaved apoptotic self antigens in HIV infection 69
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: in-hospital evaluation and one-year follow-up 69
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 68
Cardiovascular risk and dyslipidemia among persons living with HIV. A review 68
Totale 8.849
Categoria #
all - tutte 53.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019973 0 0 0 0 0 0 0 0 0 0 524 449
2019/20203.746 422 114 63 180 406 682 555 410 381 266 122 145
2020/20212.278 177 213 43 234 101 237 70 134 260 404 157 248
2021/20224.338 150 210 278 219 433 176 136 467 611 244 797 617
2022/20234.397 678 837 228 461 396 321 114 742 325 71 144 80
2023/20241.998 146 309 141 191 233 284 119 269 49 250 7 0
Totale 19.342